Target intelligence / Profile preview

Leucine-rich repeat-containing protein 27 (LRRC27)

Target
LRRC27
Molecular classification
Other (Leucine-rich repeat protein)
01

Overview

Leucine-rich repeat-containing protein 27 (LRRC27) is a protein encoded by the *LRRC27* gene located on chromosome 10q26.3 in humans, with notable transcript and protein expression in the brain and testis[1][2][3]. The protein is about 530 amino acids, features 5 leucine-rich repeat regions, and is predicted to be involved in actin binding, cytoskeletal, and cardiac muscle cell functions[1][2][3][6]. While its biological function is not fully defined, LRRC27 is implicated in disease processes such as preeclampsia (through platelet expression), primary open-angle glaucoma (through an associated SNP), and as an epigenetic biomarker for metabolic interventions[1][2][3]. There is no current evidence that LRRC27 is a direct therapeutic target, nor are there drugs known to modulate its function specifically. Its classification falls under "Other" as a leucine-rich repeat protein without established receptor, transporter, enzyme, or signaling protein functions[1][2][3][6].

Other names
KIAA1674Testicular tissue protein Li 108leucine rich repeat containing 27LRRC27
02

Biological functions

Actin binding (predicted)Cardiac muscle cell development (predicted)Cytoskeletal organization (predicted)Sarcomere structure (predicted)Inflammatory and stress-related signaling (implied/epigenetic regulation)
03

Disease associations

PreeclampsiaPrimary open-angle glaucomaBardet-Biedl syndrome 2 (reported association, but not primary disease gene)Fanconi anemia, complementation group C (reported association, but not primary disease gene)Metabolic responsiveness/obesity (biomarker for weight-loss intervention efficacy)
04

Biomarkers

Differential DNA methylation associated with weight loss responsivenessOverexpression in platelets in preeclampsiaDisease-associated SNP (rs116121322) in glaucoma

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 27 (LRRC27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 27 (LRRC27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call